Celludoxa Sanovazo Trauma Dressing" is a Class II medical device topical dressing that incorporates a topical formulation developed by Charsire Biotechnology Corp. It contains extracts derived from patented manufacturing processes, granted patents in various countries. The dressing's primary function is to maintain moisture in superficial wounds. Utilizing Celludoxa Sanovazo in skin side-effect care for cancer radiotherapy can provide significant benefits to patients worldwide and generate global revenue for the company.
